Game Plan Financial Advisors, LLC Hoth Therapeutics, Inc. Transaction History

Game Plan Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$0.38 - $1.05 $1,710 - $4,725	4,500 Added 18.37%	29,000 $12,000
Q1 2022 Apr 22, 2022	SELL	$0.52 - $1.3 $2,860 - $7,150	-5,500 Reduced 18.33%	24,500 $17,000
Q4 2021 Feb 14, 2022	BUY	$0.66 - $1.18 $19,800 - $35,400	30,000 New	30,000 $20,000
Q3 2020 Nov 09, 2020	SELL	$1.86 - $3.15 $19,995 - $33,862	-10,750 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$2.53 - $4.08 $27,197 - $43,860	10,750 New	10,750 $28,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.04M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.